Navigation Links
DHA in Diet Helps Delay Onset of Alzheimer's

California – A kind of Omega-3 fatty acid called DHA, present in fish, eggs, organ meats, fortified foods and food supplements assists in delaying// the arrival of Alzheimer's disease.

Scientists from the University of California conducted a study on mice to investigate the effects of DHA; they found that DHA reduced the levels of the protein called beta amyloid, which comes together to form plaques in the brain.

Study co-author Frank LaFerla said, “We are greatly excited by these results, which show us that simple changes in diet can positively alter the way the brain works and lead to protection from Alzheimer's disease pathology.”

Kim Green, the lead author of this study was extremely hopeful of the power of mental stimulation, exercise, and a good diet with DHA, as a method to delay the onset of Alzheimer's disease.

This study is published in The Journal of Neuroscience.
SV
'"/>




Page: 1

Related medicine news :

1. Antibiotics Helps Autism
2. Serum Progesterone Helps Stratify Ectopic Pregnancy Risk
3. Prescription Drug - Helps People Stop Smoking
4. New Drug PP188 Helps Sickle Cell Disease
5. Red Wine Helps Fight Heart disease
6. Creatine Helps Strengthen Older Men
7. Cholesterol Drug Helps After Angioplasty
8. Virus Helps Remove Brain Cancer
9. Eating Fish Helps the Heart
10. Antidepressant Helps Relieve Hot Flashes
11. Epilepsy Drug Helps Diabetic Nerve Damage
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: DHA Diet Helps Delay Onset Alzheimer

(Date:12/2/2008)...ire/ -- In response to the commentary entitled "Co...ory Infections, and the Vitamin D Deficiency Epide...upplement experts, Nordic Naturals announced today... compromise to consumers and actually offer health...al Vitamin A. According to Karin Yien, MD, Nordic ...
(Date:12/2/2008)...ollect and disseminate pharmacy experience and kno.... (PRWEB) December 2, 2008 -- Pharmacy OneSource,...ive to focus public and industry attention on med...f SPEAK will occur during the American Society of ...ical Meeting, to be held December 7-11 in Orlando,...
(Date:12/2/2008)...ealth, a leading provider of onsite health service... Balance, the athletic products company, has selec...ge onsite health clinics and to provide health ser...e , Burlington, VT (PRWEB...rovider of onsite employee health services and tec...
(Date:12/2/2008)...t of Normal Gait Deviations and Treatment Options ...s of a three-day workshop to be held at La Rabida ... Chicago, IL (PRWEB) December 2, 200...atment Options for the Child with Cerebral Palsy w...d at La Rabida Children,s Hospital Dec. 5 through ...
Breaking Medicine News(10 mins):Health News:Nordic Naturals Offers Cod Liver Oil Solutions in Response to Recent Vitamin A and Vitamin D Controversy 2Health News:Pharmacy OneSource Launches SPEAK Initiative to Promote Medication Safety Awareness 2Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 2Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 3Health News:La Rabida Children's Hospital to Host Three-Day Course on Gait Treatment Options for Children with Cerebral Palsy 2
...unday expressed concern at India's health indicato...as he urged the medical fraternity to revamp healt...den jubilee celebrations of the All India Institut... exhorted policy planners and doctors to emulate t...
...ersity Baptist Medical Center have begun a study p... steroids to prevent premature babies//. Premature... their lungs are not fully developed. Currently th...er synthetic steroids and to prolong the pregnancy...
...rganisation one in three women and one in seven m...at some point after the age of 50.The recommended ...8 and 50 years is 1000mg. Calcium, together with v...and helps in preventing brittle bone disease oste...
... contributor in the plant kingdom among pulses. Be... protein it is also known to have numerous other h...d, shown to lower cholesterol, slow the developmen...alth. Sometime back it was supposed to be extra b...
Other Medicine News:Health News:Medical Fraternity Urged To Revamp Indian Healthcare 2
(Date:12/1/2008)...ec. 1 GeoVax Labs, Inc.,...echnology company developing,human vaccines for d...rus) and,other infectious agents, announced today...ials will take place in twelve sites across North ...collaboration with The National Institutes of,Hea...
(Date:11/28/2008)...IS, Nov. 28 Eli Lilly an...mental New Drug Application (sNDA) from,the U.S. ... (duloxetine HCl),for the management of chronic p...he first half of 2009, adding data from a recently...is pain of the knee. , The decision does no...
(Date:11/25/2008)...areness can improve recovery , , Audio and ...ailable on the Mayo Clinic News Blog. Please see t..., ROCHESTER, Minn., Nov. 25 /PRNewswire-USNewsw...roke patients don,t think they,re having a stroke ...l their condition worsens. The findings appear in ...
(Date:11/25/2008)... Calif., Nov. 25 Pharmac...at the company has completed a Phase 1,clinical t...-class,small-molecule Factor VIIa inhibitor. The ...teers to evaluate the safety and pharmacologic eff...27483 resulted in a linear dose,response in the I...
Breaking Medicine Technology:GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4FairWarning to Host Webinar Featuring HIMSS Chairman and Healthcare Executive from PricewaterhouseCoopers on Electronic Health Record Privacy and Comp 11766 1FairWarning to Host Webinar Featuring HIMSS Chairman and Healthcare Executive from PricewaterhouseCoopers on Electronic Health Record Privacy and Comp 11766 2The Brand Experience Teams With World Vision to Launch Experience 3A AIDS Multi Media Exhibit 11763 1The Brand Experience Teams With World Vision to Launch Experience 3A AIDS Multi Media Exhibit 11763 2The Brand Experience Teams With World Vision to Launch Experience 3A AIDS Multi Media Exhibit 11763 3Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin 28TM 29 11760 1Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin 28TM 29 11760 2Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin 28TM 29 11760 3AAFPRS Speaks to the Safety of BOTOX 28R 29 Cosmetic 11759 1AAFPRS Speaks to the Safety of BOTOX 28R 29 Cosmetic 11759 2
...geting Pro-Inflammatory,Protein -, GAITHERSBURG, M...mune, Inc. today announced the publication of prec...obility group box,protein-1 (HMGB1), a nuclear DNA...oimmune diseases such as systemic lupus,erythemato...to be,published in the May 2007 issue of Nature Im...
...wire-FirstCall/ --,VioQuest Pharmaceuticals, Inc. ...used on acquiring, developing and,commercializing ...,preclinical studies of VQD- 002, a direct inhibit...d hematologic tumors.,Pre-clinical data was presen...f the American Association for Cancer Research,(AA...
Other Medicine Technology:MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 2MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: